You have 9 free searches left this month | for more free features.

Condition

Advanced Solid Tumor (1)

Metastatic Castration-resistant Prostate Cancer (1)

Prostate Cancer (1)

Overall Status

Active, not recruiting (1)

Recruiting (1)

Sign in for free

Phase

phase 1 (1)

phase 2 (1)

Sponsor

Surface Oncology (2)

Collaborator

Arcus Biosciences, Inc. (1)

Merck Sharp & Dohme LLC (1)

Intervention

srf617 (2)

albumin-bound paclitaxel (1)

etrumadenant (1)

gemcitabine (1)

pembrolizumab (1)

zimberelimab (1)

Study Documents

Intervention Type

drug (2)

Funder Type

Industry (2)

Study Type

Interventional (2)

srf617

Showing 1 - 2 of 2

Trials per page:

STUDY

CONDITIONS

INTERVENTIONS

LOCATIONS

Advanced Solid Tumor Trial in Canada, United States (SRF617, Gemcitabine, Albumin-Bound Paclitaxel)

Active, not recruiting

Advanced Solid Tumor

SRF617
+3 more

Duarte, California
+9 more

Nov 28, 2022

Metastatic Castration-resistant Prostate Cancer, Prostate Cancer Trial in United States (SRF617, etrumadenant, zimberelimab)

Recruiting

Metastatic Castration-resistant Prostate Cancer
Prostate Cancer

SRF617
+2 more

Miami, Florida
+6 more

Jun 13, 2022